Optimizing a Doxycycline-Dependent SIV Variant
Author Information
Author(s): Das Atze T, Klaver Bep, Centlivre Mireille, Harwig Alex, Ooms Marcel, Page Mark, Almond Neil, Yuan Fang, Piatak Mike Jr, Lifson Jeffrey D, Berkhout Ben
Primary Institution: Academic Medical Center of the University of Amsterdam
Hypothesis
Can in vitro evolution improve the replication efficiency of a doxycycline-dependent simian immunodeficiency virus (SIV) variant?
Conclusion
The dox-dependent SIV-rtTA variant was optimized by viral evolution, yielding variants that can be used to test the conditionally live virus vaccine approach and as a tool in SIV biology studies and vaccine research.
Supporting Evidence
- The dox-dependent SIV-rtTA variant was constructed to replicate only in the presence of doxycycline.
- Long-term culturing revealed additional mutations that improved viral replication.
- The optimized variants maintained dox-control while enhancing replication efficiency.
Takeaway
Scientists made a special virus that only works when a medicine is present, and they improved it so it can help test vaccines safely.
Methodology
The study involved long-term culturing of a doxycycline-dependent SIV variant to observe mutations that enhance its replication.
Limitations
The study does not address the long-term safety of the evolved variants in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website